Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

831 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients. Insights from the RAVEL Trial.
Abizaid A, Costa MA, Blanchard D, Albertal M, Eltchaninoff H, Guagliumi G, Geert-Jan L, Abizaid AS, Sousa AG, Wuelfert E, Wietze L, Sousa JE, Serruys PW, Morice MC; Ravel Investigators. Abizaid A, et al. Among authors: blanchard d. Eur Heart J. 2004 Jan;25(2):107-12. doi: 10.1016/j.ehj.2003.11.002. Eur Heart J. 2004. PMID: 14720526 Clinical Trial.
Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial.
Fajadet J, Morice MC, Bode C, Barragan P, Serruys PW, Wijns W, Constantini CR, Guermonprez JL, Eltchaninoff H, Blanchard D, Bartorelli A, Laarman GJ, Perin M, Sousa JE, Schuler G, Molnar F, Guagliumi G, Colombo A, Ban Hayashi E, Wülfert E. Fajadet J, et al. Among authors: blanchard d. Circulation. 2005 Mar 1;111(8):1040-4. doi: 10.1161/01.CIR.0000156334.24955.B2. Epub 2005 Feb 21. Circulation. 2005. PMID: 15723977 Free article. Clinical Trial.
6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial.
Gilard M, Barragan P, Noryani AAL, Noor HA, Majwal T, Hovasse T, Castellant P, Schneeberger M, Maillard L, Bressolette E, Wojcik J, Delarche N, Blanchard D, Jouve B, Ormezzano O, Paganelli F, Levy G, Sainsous J, Carrie D, Furber A, Berland J, Darremont O, Le Breton H, Lyuycx-Bore A, Gommeaux A, Cassat C, Kermarrec A, Cazaux P, Druelles P, Dauphin R, Armengaud J, Dupouy P, Champagnac D, Ohlmann P, Endresen K, Benamer H, Kiss RG, Ungi I, Boschat J, Morice MC. Gilard M, et al. Among authors: blanchard d. J Am Coll Cardiol. 2015 Mar 3;65(8):777-786. doi: 10.1016/j.jacc.2014.11.008. Epub 2014 Nov 16. J Am Coll Cardiol. 2015. PMID: 25461690 Free article. Clinical Trial.
[Use of coronary stents].
Chevalier B, Eltchaninoff H, Blanchard D, Finet G, Bedossa M, Corcos T, Fourrier JL, Hanssen M, Lefèvre T, Puel J. Chevalier B, et al. Among authors: blanchard d. Arch Mal Coeur Vaiss. 2003 Mar;96(3):163-74. Arch Mal Coeur Vaiss. 2003. PMID: 12722545 Review. French. No abstract available.
Short and long-term outcomes of alcohol septal ablation with the trans-radial versus the trans-femoral approach: A single center-experience.
Sawaya FJ, Louvard Y, Spaziano M, Morice MC, Hage F, El-Khoury C, Roy A, Garot P, Hovasse T, Benamer H, Unterseeh T, Chevalier B, Champagne S, Piechaud JF, Blanchard D, Cormier B, Lefèvre T. Sawaya FJ, et al. Among authors: blanchard d. Int J Cardiol. 2016 Oct 1;220:7-13. doi: 10.1016/j.ijcard.2016.06.127. Epub 2016 Jun 25. Int J Cardiol. 2016. PMID: 27372037
[Drug-eluting stents: indications, limits and future development].
Chevalier B, Blanchard D, Berland J, Carrié D, Gilard M, Hanssen M, Louvard Y, Eltchaninoff H; Groupe Athérome Coronaire et Cardiologie Interventionnelle de la Sociéte Française de Cardiologie. Chevalier B, et al. Among authors: blanchard d. Arch Mal Coeur Vaiss. 2005 Oct;98(10):1013-21. Arch Mal Coeur Vaiss. 2005. PMID: 16294549 Review. French. No abstract available.
Use of drug eluting stents: expert consensus of the French Society of Cardiology.
Danchin N, Blanchard D, Chevalier B, Eltchaninoff H, Ferrières J, Steg PG, Machecourt J. Danchin N, et al. Among authors: blanchard d. Arch Cardiovasc Dis. 2008 Mar;101(3):190-3. doi: 10.1016/s1875-2136(08)71802-3. Arch Cardiovasc Dis. 2008. PMID: 18477947 Free article. Review. No abstract available.
Rationale and design of the Cyclosporine to ImpRove Clinical oUtcome in ST-elevation myocardial infarction patients (the CIRCUS trial).
Mewton N, Cung TT, Morel O, Cayla G, Bonnefoy-Cudraz E, Rioufol G, Angoulvant D, Guerin P, Elbaz M, Delarche N, Coste P, Vanzetto G, Metge M, Aupetit JF, Jouve B, Motreff P, Tron C, Labeque JN, Steg PG, Cottin Y, Range G, Clerc J, Coussement P, Prunier F, Moulin F, Roth O, Belle L, Dubois P, Barragan P, Gilard M, Piot C, Colin P, Morice MC, Monassier JP, Ider O, Dubois-Randé JL, Unterseeh T, Lebreton H, Beard T, Blanchard D, Grollier G, Malquarti V, Staat P, Sudre A, Hansson MJ, Elmer E, Boussaha I, Jossan C, Torner A, Claeys M, Garcia-Dorado D, Ovize M; CIRCUS Study Investigators. Mewton N, et al. Among authors: blanchard d. Am Heart J. 2015 Jun;169(6):758-766.e6. doi: 10.1016/j.ahj.2015.02.020. Epub 2015 Mar 13. Am Heart J. 2015. PMID: 26027612 Free article. Clinical Trial.
831 results